jeudi 3 novembre 2016

Onco Actu du 3 novembre 2016

1. Biologie

Single-cell analysis supports a role for cancer stem cells in brain tumor growth [Massachusetts General Hospital]

Science Snaps: understanding where breast cancer stems from [Cancer Research UK]

3.1.1 Tabac - e-cigs

Some e-cig sweeteners may make toxic fumes at cigarette levels [Reuters]

4.10 Dép., diag. & prono. - Poumon

MD Anderson-led study develops prediction model for lung cancer risk in never smokers [MD Anderson]

5.12 Immunothérapies

Exploring the promise and challenges of cancer immunotherapy [Stanford Medicine]

Some immune-boosting cancer drugs may pose rare heart risks [STAT]

Fulminant Myocarditis with Combination Immune Checkpoint Blockade [Now@NEJM]

Lifesaving Cancer Drugs May in Rare Cases Threaten the Heart [NY Times]

5.12.3 Immunothérapies-combinaisons

New Data Presentations at SITC 2016 Annual Meeting Highlight Bristol-Myers Squibb’s Leadership in Advancing the Science of Immuno-Oncology Combinations [BMS]

5.2 Pharma

Tesaro Announces Submission of Niraparib New Drug Application for Platinum-Sensitive, Recurrent Ovarian Cancer [Tesaro]

Oncolytic contender Turnstone bags a $41M B round to push a successor for Imlygic [EndPoints]

On the ropes, Infinity gets a deal for duvelisib, with $0 up front as PI3k flounders [EndPoints]

5.2.1 Pharma - Partenariats

Here’s the Surprising Reason IBM Is Partnering With Celgene [Fortune]

5.2.3 Pharma - économie

The backlash over high drug prices is hitting pharma where it hurts [STAT]

5.4 Traitements - Economie

Life-extending breast cancer drug approved by NICE in draft guidance [NICE]

UK regulator approves drug that could extend lives of breast cancer patients [The Guardian]

Eisai latest cancer drugmaker to win UK approval after price cut [Reuters]

6. Lutte contre les cancers

What's Next For Precision Medicine? [Fast Company]

Palliative care should be standard in cancer treatment: guideline [Reuters]

Device Lets Cancer Patients Assist in their Own Breast Reconstruction, at Home [MIT Technology Review]

6.1 Observation

Current system unlikely to pick up surgeons with above average patient death rates [BMJ Blogs]

6.11 Patients

New U.S. Survey Sheds Light on the Experiences of People Caring for Someone Living with Lung Cancer [BMS]